These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19528309)

  • 1. Chronic kidney disease and bisphosphonate treatment: are prescribing guidelines unnecessarily restrictive?
    Courtney AE; Maxwell AP
    Postgrad Med J; 2009 Jun; 85(1004):327-30. PubMed ID: 19528309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kidney and bisphosphonates.
    Miller PD
    Bone; 2011 Jul; 49(1):77-81. PubMed ID: 21232648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of SERMs on bone health. The potential of SERM in the care of chronic kidney disease-mineral bone and disorders].
    Hamano T
    Clin Calcium; 2010 Mar; 20(3):373-9. PubMed ID: 20190367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary osteoporosis UPDATE. Bone disease with decreased kidney function].
    Okuno S; Ishimura E
    Clin Calcium; 2010 May; 20(5):655-62. PubMed ID: 20445276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of osteoporosis in chronic renal disease.
    Miller PD
    Semin Nephrol; 2009 Mar; 29(2):144-55. PubMed ID: 19371805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critique of clinical guidelines for detection of individuals with chronic kidney disease.
    Connolly JO; Woolfson RG
    Nephron Clin Pract; 2009; 111(1):c69-73. PubMed ID: 19060500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for bisphosphonates in chronic kidney disease?
    Miller PD
    Semin Dial; 2007; 20(3):186-90. PubMed ID: 17555478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate therapy for metastatic bone disease: the pivotal role of nurses in patient education.
    Fitch MI; Maxwell C
    Oncol Nurs Forum; 2008 Jul; 35(4):709-13. PubMed ID: 18591175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rational guide to reducing fracture risk in dialysis patients.
    Toussaint ND; Elder GJ; Kerr PG
    Semin Dial; 2010; 23(1):43-54. PubMed ID: 20331818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
    Bakris GL; Ritz E;
    J Hum Hypertens; 2009 Mar; 23(3):222-5. PubMed ID: 19158823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes associated with hypogonadism in women with chronic kidney disease.
    Weisinger JR; Bellorin-Font E
    Adv Chronic Kidney Dis; 2004 Oct; 11(4):361-70. PubMed ID: 15492973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.
    Miller PD
    Curr Osteoporos Rep; 2005 Mar; 3(1):5-12. PubMed ID: 16036095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of bisphosphonates in the treatment of osteoporosis.
    Recker RR; Lewiecki EM; Miller PD; Reiffel J
    Am J Med; 2009 Feb; 122(2 Suppl):S22-32. PubMed ID: 19187809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral bisphosphonate therapy on serum calcium in elderly veterans with poor kidney function.
    Vouri SM; Alvarez CA; Blaszczyk AT
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):178-84. PubMed ID: 22542895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
    Tsukamoto Y
    Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate use in patients undergoing dialysis.
    Vouri SM; Blaszczyk AT
    Consult Pharm; 2013 Nov; 28(11):738-41. PubMed ID: 24217193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.
    Nogueira J; Weir M
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):766-85. PubMed ID: 17699494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.